158 related articles for article (PubMed ID: 37848807)
21. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
22. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
23. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
[TBL] [Abstract][Full Text] [Related]
24. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
25. A radiomics-based nomogram for the preoperative prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma.
Cai W; He B; Hu M; Zhang W; Xiao D; Yu H; Song Q; Xiang N; Yang J; He S; Huang Y; Huang W; Jia F; Fang C
Surg Oncol; 2019 Mar; 28():78-85. PubMed ID: 30851917
[TBL] [Abstract][Full Text] [Related]
26. Predicting Ki-67 expression in hepatocellular carcinoma: nomogram based on clinical factors and contrast-enhanced ultrasound radiomics signatures.
Zhang D; Zhang XY; Lu WW; Liao JT; Zhang CX; Tang Q; Cui XW
Abdom Radiol (NY); 2024 May; 49(5):1419-1431. PubMed ID: 38461433
[TBL] [Abstract][Full Text] [Related]
27. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.
Chong HH; Yang L; Sheng RF; Yu YL; Wu DJ; Rao SX; Yang C; Zeng MS
Eur Radiol; 2021 Jul; 31(7):4824-4838. PubMed ID: 33447861
[TBL] [Abstract][Full Text] [Related]
28. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
Ma X; Wei J; Gu D; Zhu Y; Feng B; Liang M; Wang S; Zhao X; Tian J
Eur Radiol; 2019 Jul; 29(7):3595-3605. PubMed ID: 30770969
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.
Yuan G; Song Y; Li Q; Hu X; Zang M; Dai W; Cheng X; Huang W; Yu W; Chen M; Guo Y; Zhang Q; Chen J
Front Immunol; 2020; 11():613946. PubMed ID: 33488622
[TBL] [Abstract][Full Text] [Related]
30. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.
Peng J; Zhang J; Zhang Q; Xu Y; Zhou J; Liu L
Diagn Interv Radiol; 2018; 24(3):121-127. PubMed ID: 29770763
[TBL] [Abstract][Full Text] [Related]
31. Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm.
Zheng R; Zhang X; Liu B; Zhang Y; Shen H; Xie X; Li S; Huang G
Eur Radiol; 2023 Sep; 33(9):6462-6472. PubMed ID: 37338553
[TBL] [Abstract][Full Text] [Related]
32. Radiomics nomogram for prediction of microvascular invasion in hepatocellular carcinoma based on MR imaging with Gd-EOB-DTPA.
Zhang S; Duan C; Zhou X; Liu F; Wang X; Shao Q; Gao Y; Duan F; Zhao R; Wang G
Front Oncol; 2022; 12():1034519. PubMed ID: 36387156
[TBL] [Abstract][Full Text] [Related]
33. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.
Zheng BH; Liu LZ; Zhang ZZ; Shi JY; Dong LQ; Tian LY; Ding ZB; Ji Y; Rao SX; Zhou J; Fan J; Wang XY; Gao Q
BMC Cancer; 2018 Nov; 18(1):1148. PubMed ID: 30463529
[TBL] [Abstract][Full Text] [Related]
34. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion.
Sheen H; Kim JS; Lee JK; Choi SY; Baek SY; Kim JY
Abdom Radiol (NY); 2021 Jun; 46(6):2839-2849. PubMed ID: 33388805
[TBL] [Abstract][Full Text] [Related]
35. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
36. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
Feng ST; Jia Y; Liao B; Huang B; Zhou Q; Li X; Wei K; Chen L; Li B; Wang W; Chen S; He X; Wang H; Peng S; Chen ZB; Tang M; Chen Z; Hou Y; Peng Z; Kuang M
Eur Radiol; 2019 Sep; 29(9):4648-4659. PubMed ID: 30689032
[TBL] [Abstract][Full Text] [Related]
37. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram.
Zhao JW; Shu X; Chen XX; Liu JX; Liu MQ; Ye J; Jiang HJ; Wang GS
Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):543-550. PubMed ID: 35705443
[TBL] [Abstract][Full Text] [Related]
38. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
39. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver.
Ding Z; Lin K; Fu J; Huang Q; Fang G; Tang Y; You W; Lin Z; Lin Z; Pan X; Zeng Y
World J Surg Oncol; 2021 Jun; 19(1):181. PubMed ID: 34154624
[TBL] [Abstract][Full Text] [Related]
40. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma.
Gong XQ; Liu N; Tao YY; Li L; Li ZM; Yang L; Zhang XM
Sci Rep; 2023 May; 13(1):7710. PubMed ID: 37173350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
